1[1]Franceschi S.The IARCcommitment to cancer prevention:the example of papillomavirus and cervical cancer[J].Recent Results Cancer Res,2005,166:277-297.
2[2]Hou Y D.Motecular Virology[M].Beijing:China Academic Press,1990:196-202
3[3]Bosch FX,Lorincz A,Munoz N,et al.The causal relation between human pap illomavirus and cervical cancer[J].J Clin Pathol,2002,55(4):244-265.
4[4]Cha X L.Medical Molecular Biology[M].Beiing:People's Medical Publishing House,2003:523.
5[5]Kirnbauer R,Booy F,ChengN,et al.Pap illomavirusL1 major capsid protein self-assembles into virus-like particles that are highly immunogenic[J].Proc Natl Acad Sci U S A,1992,89(24):12180-12184.
6[6]Harper DM,Franco EL,Wheeler C,et al.Efficacy of a bivalent L1 viruslike particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women:a randomised controlled trial[J].Lancet,2004,364:1757-1765.
7[7]Zwaveling S,Ferreira Mota SC,Nouta J,et al.Established human papillomavirus type 16-expressing tumors are effectively eradicated following vaccination with long peptides[J].J Immunol,2002,169(1):350-358.
8[8]Daemen T; Riezebos-Brilman A,Regts J,et al.ASuperior therapeut-ic efficacy of alphavirus-mediated immunization against human papillo-ma virus type 16 antigens in a murine tumour model:effects of the route of immunization[J].Antivir.Ther,2004,9(5):733-742.
9[9]Furumoto H,Irahara M.Human papilloma virus (HPV) and cervical cancer[J].J Med Invest,2002,49(3-4):124.
10[10]Herrero R,Hildesheim A,Bratti C,et al.Population-based study of human papillomavirus infection and cervical neoplasia in rural Cos-ta Rica[J].J Natl Cancer Inst,2000,92 (6):464-474.
